Sangamo Therapeutics Announces Departure of Chief Economical Officer Sung Lee
Press release written content from Small business Wire. The AP information staff members was not associated in its generation.
BRISBANE, Calif.–(Business enterprise WIRE)–Jan 6, 2021–
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic drugs company, introduced currently that Chief Money Officer Sung Lee is leaving the Corporation to go after a new possibility overseas. Mr. Lee’s last day of work will be February 1, 2021.
“Sung has contributed considerably to Sangamo’s evolution, aiding us construct a solid cash place to progress proprietary medicines for sufferers in need to have as we commence a year with many potential catalysts,” reported Sandy Macrae, Chief Govt Officer of Sangamo. “I have deep appreciation for the integrity and leadership Sung introduced to Sangamo. The administration group and board of administrators at Sangamo sign up for me in wishing him the incredibly ideal as we initiate our lookup for a new CFO.”
“It has been a privilege to do the job with Sandy and the Sangamo workforce to advance the modern subject of genomic medication, and I think the company is properly positioned to execute on its strategy,” mentioned Mr. Lee.
About Sangamo Therapeutics
Sangamo Therapeutics is fully commited to translating floor-breaking science into genomic medications with the opportunity to transform patients’ lives employing gene remedy, ex vivo gene-edited mobile therapy, and in vivo genome enhancing and genome regulation. For much more information about Sangamo, go to www.sangamo.com.
Look at source version on businesswire.com:https://www.businesswire.com/information/home/20210106005808/en/
Speak to: Investor Relations & Media Inquiries
Aron Feingold
628.252.7494
Search phrase: CALIFORNIA UNITED STATES NORTH The usa
Market Search phrase: Well being GENETICS Research PHARMACEUTICAL SCIENCE BIOTECHNOLOGY
Supply: Sangamo Therapeutics, Inc.
Copyright Organization Wire 2021.
PUB: 01/06/2021 04:10 PM/DISC: 01/06/2021 04:10 PM
http://www.businesswire.com/information/house/20210106005808/en
